PATENT CLAIM ANALYSIS

Application Number: 16083016
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "361000"]

Abstract:
Provided herein are methods of treating a CDKL5 deficiency with tideglusib or a derivative thereof.

Claim (Index 8):
The method of  claim 1 , wherein the amount ranges from about 2 mg/kg bodyweight to about 50 mg/kg bodyweight.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 97.0
- Lexical Diversity: 1.06667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14633757', '15954021', '15075457', '15125796', '14108531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7385899151474856
- 35 USC 102 Novelty (BERT): 0.5377551305028422
- Combined Prediction Score: 0.7185064366830214
- Mean Citation Score: 266.73510600000003
- Max Citation Score: 327.64758
- Similarity Product: 178.45861144818662

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test